Similarly, Herrera et al. reported comparable ORR and CR rates in their CHEP-BV cohort, with 93% and 67% in the CD30 1–9% group, and 90% and 87% in the CD30 > 10% group, respectively [41]. Here, TNFRSF8 is linked to bacterial vaginosis.